Stock Sale, Buyback News
Stay updated with the latest stock sale and buyback news. Read about company stock transactions, buyback programs, market impacts, and investor reactions. Discover how these financial moves influence stock prices and shareholder value.
Oct 12, 2026 at 1:39 AM
HAFNIA LIMITED: Mandatory Notification of Trade by Primary Insider
SINGAPORE--(BUSINESS WIRE)--Perry Van Echtelt, Chief Financial Officer of Hafnia Limited ("Hafnia", the "Company", OSE ticker code: "HAFNI", NYSE ticker code: "HAFN"), has on 9 October 2026 sold 50,000 shares in Hafnia at an average price of NOK 101.5203 per share on Oslo Børs. Following the share sale, Perry van Echtelt has a significant financial interest in the Company, holding a total of 563,544 shares and options. For more information see the attached mandatory notification of trade. This...
Oct 9, 2026 at 4:35 PM
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and inflammatory diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted 2 new employees options to purchase a total of 9,150 shares of the Company’s common stock at an exercise price per share of $23.83, which was the closing pric...
Oct 9, 2026 at 4:30 PM
CrowdStrike Recommends Stockholders Reject the “Mini-Tender” Offer by Tutanota LLC
AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike Holdings, Inc. (NASDAQ: CRWD) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis (“Tutanota”) to purchase up to 500,000 shares of CrowdStrike common stock at a price of $260.00 per share in cash. The offer price of $260.00 per share is conditioned on, among other things, the closing price per share of CrowdStrike common stoc...
Oct 9, 2026 at 4:05 PM
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were appr...
Oct 9, 2026 at 11:37 AM
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
SAN ANTONIO--(BUSINESS WIRE)--BIAF announces closing of $4 million registered direct financing of common stock and private placement priced at-the-market under Nasdaq rules...
Oct 9, 2026 at 5:37 AM
Eurofins Scientific: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the per...
Oct 8, 2026 at 10:03 PM
Crescent Energy Company Announces Pricing of Public Offering of Class A Common Stock
HOUSTON--(BUSINESS WIRE)--Crescent Energy Company (“Crescent” or the “Company”) (NYSE: CRGY) today announced the pricing of an underwritten, public offering of 80,000,000 shares of its Class A common stock, par value $0.0001 per share (“Class A common stock”), at a price to the public of $12.50 per share, pursuant to an effective shelf registration statement on Form S-3 (the “Registration Statement”) filed previously with the U.S. Securities and Exchange Commission (the “SEC”).The Company intend...
Oct 8, 2026 at 4:05 PM
Calix Increases Stock Repurchase Authorization by An Additional $100 Million
SAN JOSE, Calif.--(BUSINESS WIRE)--Calix, Inc. (NYSE: CALX) today announced that its board of directors increased the authorization to repurchase the Company’s common stock by an additional $100 million under the existing stock repurchase program. The additional authorization is intended to provide the Company with greater flexibility to continue its disciplined capital allocation approach. Under the repurchase program, repurchases can be made from time to time using a variety of methods, which...
Oct 8, 2026 at 12:07 PM
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
SAN ANTONIO, Texas--(BUSINESS WIRE)--BIAF Announces $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules...
Oct 8, 2026 at 9:32 AM
Better Home & Finance Announces $30 Million Share Repurchase Program in Conjunction with Ramp in Cost Optimization and Sale of UK Bank initiatives
NEW YORK--(BUSINESS WIRE)--Better Home & Finance Holding Company (NASDAQ: BETR) (“Better” or the “Company”) today announced that its Board of Directors authorized the repurchase of up to $30 million of the Company’s Class A common stock. Better intends to begin repurchases with an initial $10 million phase. The program advances Better 2.0’s commitment to disciplined capital allocation as Better advances its next phase of growth. The Company intends to align the pace of the repurchases with...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.